Refining frontotemporal dementia with parkinsonism linked to chromosome 17: Introducing FTDP-17 (MAPT) and FTDP-17 (PGRN)

Archives of Neurology

Volumn 65, Issue 4, 2008, Pages 460-464

  Boeve, Bradley F ^a   Hutton, Mike ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRANULIN; TAU PROTEIN; UBIQUITIN;

CHROMOSOME 17; COGNITIVE DEFECT; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HUMAN; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; DNA MUTATIONAL ANALYSIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PARKINSONIAN DISORDERS; PHENOTYPE; TAU PROTEINS;

EID: 42249085980     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.4.460     Document Type: Review

References (31)

1. Foster NL, Wilhelmsen K, Sima A, Jones MZ, D'Amato CJ, Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol. 1997;41(6):706-715.
2. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702-705.
3. Alzheimer Disease & Frontotemporal Dementia Mutation Database. http://www.molgen.ua.ac.be/FTDmutations/. Accessed February 14, 2007.
4. Poorkaj P, Grossman M, Steinbart E, et al. Frequency of tau gene mutations in familial and sporadic cases of non-Alzheimer dementia. Arch Neurol. 2001;58(3):383-387.
5. Kertesz A. Pick's complex and FTDP-17. Mov Disord. 2003;18(suppl 6):S57-S62.
6. Boeve BF, Tremont-Lukats I, Waclawik A, et al. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain. 2005;128(pt 4):752-772.
7. Frank AR, Wszolek ZK, Jack CR Jr, Boeve BF. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology. 2007;68(8):620-621.
8. Noble W, Planel E, Zehr C, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A. 2005;102(19):6990-6995.
9. Zhang B, Maiti A, Shively S, et al. Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model. Proc Natl Acad Sci U S A. 2005;102(1):227-231.
10. Lendon CL, Lynch T, Norton J, et al. Hereditary dysphasic disinhibition dementia: a frontotemporal dementia linked to 17q21-22. Neurology. 1998;50(6):1546-1555.
11. Rademakers R, Cruts M, Dermaut B, et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval. Mol Psychiatry. 2002;7(10):1064-1074.
12. van der Zee J, Rademakers R, Engelborghs S, et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain. 2006;129(pt 4):841-852.
13. Mackenzie IR, Baker M, West G, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain. 2006;129(pt 4):853-867.
14. Baker M, Mackenzie I, Pickering-Brown S, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916-919.
15. Benussi L, Binetti G, Sina E, et al. A novel deletion in progranulin gene is associated with FTDP-17 and CBS [published online ahead of print December 5, 2006]. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2006.10.028.
16. Boeve BF, Baker M, Dickson D, et al. Frontotemporal dementia and parkinsonism associated with the IVS1 + 1G->A mutation in progranulin: a clinicopathologic study. Brain. 2006;129(pt 11):3103-3114.
17. Cruts M, Gijselinck I, van der Zee J, et al. Null mutations in progranulin cause ubiquitin positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920-924.
18. Gass J, Cannon A, Mackenzie I, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet. 2006;15(20):2988-3001.
19. Huey ED, Grafman J, Wassermann EM, et al. Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol. 2006;60(3):374-380.
20. Mackenzie IR, Baker M, Pickering-Brown S, et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain. 2006;129(pt 11):3081-3090.
21. Masellis M, Momeni P, Meschino W, et al. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain. 2006;129(pt 11):3115-3123.
22. Mukherjee O, Pastor P, Cairns NJ, et al. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann Neurol. 2006;60(3):314-322.
23. Pickering-Brown SM, Baker M, Gass J, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain. 2006;129(pt 11):3124-3126.
24. Snowden JS, Pickering-Brown S, Mackenzie I, et al. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain. 2006;129(pt 11):3091-3102.
25. Kelley BJ, Haidar W, Boeve BF, et al. Prominent phenotypic variability associated with mutations in Progranulin [published online ahead of print October 18, 2007]. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2007.08. 022.
26. Mesulam M, Johnson N, Krefft T, et al. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch Neurol. 2007;64(1):43-47.
27. Rosenberg RN. Progranulin and tau gene mutations both as cause for dementia: 17q21 finally defined. Arch Neurol. 2007;64(1):18-19.
28. Krefft TA, Graff-Radford N, Dickson D, et al. Familial primary progressive aphasia. Alzheimer Dis Assoc Disord. 2003;17(2):106-112.
29. Boeve BF, Maraganore DM, Parisi JE, et al. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement Geriatr Cogn Disord. 2002;13(2):80-90.
30. Josephs KA, Ahmed Z, Katsuse O, et al. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J Neuropathol Exp Neurol. 2007;66(2):142-151.
31. Neumann M, Sampathu D, Kwong L, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130-133.